Skip to the page

Data / Drug companies / Laboratorio Magnachem International SRL

Laboratorio Magnachem International SRL: 14 products in the FDA NDC directory, labeler code 65131

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Laboratorio Magnachem International SRL (labeler code 65131) lists 14 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on April 21, 2025.

The request: Watch Laboratorio Magnachem International SRL (FDA labeler code 65131): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
65131
Products in commercial distribution
14
Packages
15
Finished drugs by generic name
6
Prescription products
0
Over the counter products
14
Flagged as original packager
14 of 14 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
January 1, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs14100%

Products by type

TypeProductsShare
Over the counter drugs14100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Dextromethorphan hbr-gyaifenesin21
Acetaminophen-phenylephrine hcl-guaifenesin21
Dextromethorphan hbr-pyrilamine maleate21
Dextromethorphan hbr-guaifenesin11
Cholpheniramine maleate-phenylephrine hcl11
Chlorpheniramine maleate-dextromethrophan hbr11

Dosage forms

Dosage formProductsShare
Syrup1178.6%
Tablet, coated214.3%
Granule, for solution17.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Broncochem maximum cough night65131-110SyrupOver the counter monograph drugsApril 21, 2025
Broncochem kids cold and flu65131-109SyrupOver the counter monograph drugsApril 21, 2025
Broncochem maximum cough65131-100SyrupOver the counter monograph drugsApril 21, 2025
Broncochem expectorant ii65131-011SyrupOver the counter monograph drugsApril 21, 2025
Broncochem maximum cough night65131-035SyrupOver the counter monograph drugsFebruary 9, 2024
Broncochem kids allergy control65131-418SyrupOver the counter monograph drugsMay 1, 2017
Broncochem maximum cough kids65131-180SyrupOver the counter monograph drugsMay 1, 2017
Broncochem kids cold and flu65131-054SyrupOver the counter monograph drugsMay 1, 2017
Broncochem allergy control65131-098SyrupOver the counter monograph drugsApril 1, 2017
Broncochem expectorant ii65131-116SyrupOver the counter monograph drugsDecember 30, 2016
Broncochem maximum cough65131-091SyrupOver the counter monograph drugsDecember 30, 2016
Broncochem cold and flu tea65131-097Granule, for solutionOver the counter monograph drugsSeptember 1, 2013
Broncochem cold and flu caplets65131-111Tablet, coatedOver the counter monograph drugsJanuary 1, 2010
Broncochem cold and flu caplets65131-101Tablet, coatedOver the counter monograph drugsJanuary 1, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.